Psychiatr. praxi. 2022;23(2):64-71 | DOI: 10.36290/psy.2022.017

Schizophrenia and obsessive compulsive disorder

MUDr. Kristýna Vrbová1, prof. MUDr. Ján Praško Pavlov, CSc.1, 2, 3, MUDr. František Hodný1, MUDr. Marie Ocisková1, MUDr. Jakub Vaněk1, MUDr. Michaela Holubová4, 5, MUDr. Jonáš Boček1, MUDr. Lucie Bundárová1
1 Klinika psychiatrie, Lékařská fakulta, Univerzita Palackého v Olomouci, Fakultní nemocnice Olomouc
2 Katedra psychologických vied, Fakulta sociálnych vied a zdravotnictva, Univerzita Konštantína Filozofa v Nitre, Slovenská republika
3 Katedra psychoterapie, IPVZ Praha
4 Krajská nemocnice Liberec, Centrum psychiatrie
5 Technická univerzita v Liberci, Fakulta Přírodovědně­‑humanitní a pedagogická, Katedra pedagogiky a psychologie

Introduction: Up to 25 % of patients with schizophrenia suffer from obsessive-compulsive symptoms (OCs), and about 12% fulfil the diagnostic criteria of obsessive-compulsive disorder (OCD). Recently, the interest in this issue has significantly increased, probably due to the finding that second-generation antipsychotics, especially clozapine, might induce or aggravate OCs. Our study aimed to describe the research findings concerning the connection between comorbid OCs and the severity and course of schizophrenia.

Method: The articles were identified by the keywords "schizophrenia comorbidity" and "obsessive compulsive disorder", using the Medline and Web of Science databases. Additional information was obtained by searching the references of relevant articles.

Results: Obsessive-compulsive symptoms or fully expressed obsessive-compulsive disorder leads to more severe overall psychopathology and worse treatment outcomes in patients without this symptomatology. The comorbidity is accompanied by more severe increased neurocognitive impairment, high levels of anxiety, depression, and suicidality, larger social and vocational disability, and greater social and health service utilization.

Conclusion: schizophrenia patients should be carefully monitored for OCs in clinical practice. The development of these symptoms may occur during disease, and early recognition and targeted treatment of this comorbidity reduce the patient´s distress and positively affect the course of the disorder and overall treatment outcomes.

Keywords: schizophrenia, comorbidity, obsessive­‑compulsive disorder, treatment outcome.

Published: June 16, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vrbová K, Praško Pavlov J, Hodný F, Ocisková M, Vaněk J, Holubová M, et al.. Schizophrenia and obsessive compulsive disorder. Psychiatr. praxi. 2022;23(2):64-71. doi: 10.36290/psy.2022.017.
Download citation

References

  1. Hunter R, MacAlpine I. Three Hundred Years of Psychiatry. London: Oxford University Press 1963.
  2. Berrios GE. Obsessive­‑compulsive disorder: its conceptual history in France during the 19th century. Compr Psychiatry. 1989;30:283-295. Go to original source... Go to PubMed...
  3. Ghaemi SN, Zarate CA, Popli AP, Pillay SS, Cole JO. Is there a relationship between clozapine and obsessive­‑compulsive disorder? A retrospective chart review. Compr Psychiatry. 1995;36:267-270. Go to original source... Go to PubMed...
  4. Khullar A, Chue P, Tibbo P. Quetiapine and obsessive-compulsive symptoms (OCS): case report and review of atypical antipsychotic induced OCS. J. Psychiatry Neurosci. 2001;26:55-59. Go to PubMed...
  5. De Haan L, Beuk N, Hoogenboom B, Dingemans P, Linszen D. Obsessive­‑compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent onset schizophrenia or related disorders. J Clin Psychiatry. 2002;63:104-107. Go to original source... Go to PubMed...
  6. Lykouras L, Alevizos B, Michalopoulou P, Rabavilas A. Obsessive­‑compulsive symptoms induced by atypical antipsychotics: a review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:333-346. Go to original source... Go to PubMed...
  7. Alevizos B, Papageorgiou C, Christodoulou GN. Obsessive­‑compulsive symptoms with olanzapine. Int J Neuropsychopharmacol. 2004;7:375-37. Go to original source... Go to PubMed...
  8. Hwang MY, Hollander E. Schizo­‑obsessive disorders. Psychiatr Ann. 1993;23:396-401. Go to original source...
  9. Zohar J. Is there room for a new diagnostic subtype: the schizoobsessive subtype? CNS Spectr. 1997;2:49-50. Go to original source...
  10. Poyurovsky M, Weizman A, Weizman R. Obsessive compulsive disorder in schizophrenia: Clinical characteristics and treatment. CNS Drugs. 2004;18(14):989-1010. Go to original source... Go to PubMed...
  11. Lysaker PH, Whitney KA. Obsessive­‑compulsive symptoms in schizophrenia: prevalence, correlates and treatment. Expert Review of Neurotherapeutics 2009;9(1):99-107. Go to original source... Go to PubMed...
  12. Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophrenia Bulletin. 2009;35(2):383-402. Go to original source... Go to PubMed...
  13. Mukhopadhaya K, KrishnaiahR, Taye T, et al. Obsessive compulsive disorder in UK clozapine­‑treated schizophrenia and schizoaffective disorder: a cause for clinical concern," Journal of Psychopharmacology. 2009;23(1):6-13. Go to original source... Go to PubMed...
  14. Achim AM, Maziade M, Raymond E, Olivier D, Merette C, Roy MA. How prevalent are anxiety disorders in schizophrenia? a meta­‑analysis and critical review on a significant Association. Schizophrenia Bulletin. 2011;37(4):811-821. Go to original source... Go to PubMed...
  15. Bosanac P, Mancuso S, Castle D. Anxiety symptoms in psychotic disorders. Clinical Schizophrenia&Related Psychoses. 2013;18:1-22. Go to original source... Go to PubMed...
  16. Hadi E, Greenberg Y, Sirota P. Obsessive compulsive symptoms in schizophrenia: prevalence, clinical features and treatment. A literature review. The World Journal of Biological Psychiatry. 2012;13(1):2-13. Go to original source... Go to PubMed...
  17. Poyurovsky M, Zohar J, Glick I, et al. Obsessive­‑compulsive symptoms in schizophrenia: implications for future psychiatric classifications," Comprehensive Psychiatry. 2012;53(5):480-483. Go to original source... Go to PubMed...
  18. Swets M, Dekker J, van Emmerik­‑van Oortmerssen K et al. The obsessive compulsive spectrum in schizophrenia, a meta­‑analysis and meta­‑regression exploring prevalence rates. Schizophrenia Research. 2014;152(2-3):458-468. Go to original source... Go to PubMed...
  19. Sharma LP, Reddy YCJ. Obsessive­‑compulsive disorder comorbid with schizophrenia and bipolar disorder. Indian Journal of Psychiatry. 2019;61(7):140-148. Go to original source... Go to PubMed...
  20. Cheng YF, Chen VCH, Yang YH, Chen KJ, Lee YC, Lu ML. Risk of schizophrenia among people with obsessive­‑compulsive disorder: A nationwide population­‑based cohort study. Schizophrenia Research. 2019;209:58-63. Go to original source... Go to PubMed...
  21. Kayahan B, Ozturk O, Veznedaroglu B, Eraslan D. Obsessive­‑compulsive symptoms in schizophrenia: prevalence and clinical correlates. Psychiatry Clin Neurosci. 2005;59(3):291-295. Go to original source... Go to PubMed...
  22. Eisen JL, Rasmussen SA. Obsessive compulsive disorder with psychotic features. J Clin Psychiatry. 1993;54(10):373-379.
  23. Kantor K, Látalová K. Schizoobsedantní příznaky. Psychiatr. praxi. 2020;21(2):74-77. Go to original source...
  24. Poyurovsky M, Fuchs C, Faragian S, Kriss V, Weisman G, Pashinian A, Weizman R, Weizman A. Preferential aggregation of obsessive­‑compulsive spectrum disorders in schizophrenia patients with obsessive­‑compulsive disorder. Can J Psychiatry. 2006;51:746-754. Go to original source... Go to PubMed...
  25. Bener A, Dafeeah E, Abou­‑Saleh M, Bhugra D, Ventriglio A. Schizophrenia and comorbid obsessive­‑compulsive disorder: Clinical characteristics. Asian Journal of Psychiatry. 2018; 37, 80-84. Go to original source... Go to PubMed...
  26. Kokurcan A, Safak Y. Assessment of obsessive­‑compulsive disorder comorbidity and obsessive­‑compulsive symptom dimensions in patients with schizophrenia. Saudi Medical Journal. 2020;41(3),275-282. Go to original source... Go to PubMed...
  27. Bräunig P, Krüger S, Shugar G, Höffler J, Börner I. The catatonia rating scale I - development, reliability, and use. Comprehensive Psychiatry. 2000;41(2),147-158. Go to original source... Go to PubMed...
  28. Woody SR, Steketee G, Chambless DL. Reliability and validity of the Yale­‑Brown Obsessive­‑Compulsive Scale. Behaviour Research and Therapy. 1995;33(5):597-605. Go to original source... Go to PubMed...
  29. De Haan L, Hoogeboom B, Beuk N, Wouters L, Dingemans PMAJ, Linszen DH. Reliability and validity of the Yale­‑Brown Obsessive­‑Compulsive Scale in schizophrenia patients. Psychopharmacology Bulletin. 2006;39(1):25-30.
  30. Bottas A, Cooke RG, Ritcher MA. Comorbidity and pathophysiology of obsessive­‑compulsive disorder in schizophrenia: is there evidence for a schizo­‑obsessive subtype of schizophrenia? J Psychiatry Neurosci. 2005;30:187-193.
  31. Beckmann H, Bartsch AJ, Neumarker KJ, Pfuhlmann B, Verdaguer MF, Franzek E. Schizophrenias in the Wernicke­‑Kleist­‑Leonhard school," American Journal of Psychiatry. 2000;157(6):1024-1025. Go to original source... Go to PubMed...
  32. Hwang MY, Kim SW, Yum SY, Opler LA. Management of schizophrenia with obsessive­‑compulsive features. Psychiatr Clin North Am. 2009;32(4):835-851. Go to original source... Go to PubMed...
  33. Niendam TA, Berzak J, Cannon TD, Bearden CE. Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome. Schizophrenia Research. 2009;108(1-3):170-175. Go to original source... Go to PubMed...
  34. Fontenelle LF, Lin A, Pantelis C, Wood SJ, Nelson WB, Yung AR. Markers of vulnerability to obsessive­‑compulsive disorder in an ultra­‑high risk sample of patients who developer psychosis. Early Intervention in Psychiatry. 2012; 6(2):201-206. Go to original source... Go to PubMed...
  35. De Vylder JE, Oh AJ, Ben­‑David S, Azimov N, Harkavy­‑Friedman JM, Corcoran CM. Obsessive compulsive symptoms in individuals at clinical risk for psychosis: Association with depressive symptoms and suicidal ideation," Schizophrenia Research. 2012;140(1-3):110-113. Go to original source... Go to PubMed...
  36. De Haan L, Sterk B, van der Valk R. Presence of obsessive compulsive symptoms in first­‑episode schizophrenia or related disorders is associated with subjective well­‑being and quality of life. Early Intervention in Psychiatry. 2013;7(3):285-290. Go to original source... Go to PubMed...
  37. Hur JW, Shin NY, Jang JH, et al. Clinical and neurocognitive profiles of subjects at high risk for psychosis with and without obsessive­‑compulsive symptoms. Australian and New Zealand Journal of Psychiatry. 2012;46(2):161-169. Go to original source... Go to PubMed...
  38. Fusar­‑Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK. Comorbid depressive and anxiety disorders in 509 individuals with an at­‑risk mental state: impact on psychopathology and transition to psychosis. Schizophrenia Bulletin. 2014;40(1):120-131. Go to original source... Go to PubMed...
  39. Kokurcan A, Nazli SB. Clinical correlates of obsessive­‑compulsive disorder comorbidity in patients with schizophrenia. Indian Journal of Psychiatry. 2020;62(1):51-58. Go to original source... Go to PubMed...
  40. Stengel E. A study on some clinical aspects of the relationship between obsessional neurosis and psychotic reaction types. J Ment Sci. 1945;91:166-187. Go to original source...
  41. Poyurovsky M, Kriss V, Weisman G, Faragian S, Kurs R, Schneidman M, Fuchs C, Weizman A, Weizman R. Comparison of Clinical characteristics and comorbidity in schizophrenia patients with and without obsessive­‑compulsive disorder: schizophrenic and OC symptoms in schizophrenia. J Clin Psychiatry. 2003;64(11):1300-1307. Go to original source... Go to PubMed...
  42. Poyurovsky M, Faragian S, Shabeta A, Kosov A. Comparison of Clinical characteristics, comorbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive­‑compulsive disorder. Psychiatry Res. 2008;159:133-139. Go to original source... Go to PubMed...
  43. Guillem F, Satterthwaite J, Pampoulova T, Stip E. Relationship between psychotic and obsessive­‑compulsive symptoms in schizophrenia. Schizophr Res. 2009;115(2-3):358-362. Go to original source... Go to PubMed...
  44. De Haan L, Hoogenboom B, Beuk N, van Amelsvoort T, Linszen D. Obsessive­‑compulsive symptoms and positive, negative, and depressive symptoms in patients with recent­‑onset schizophrenic disorders. Can J Psychiatry. 2005;50(9):519-524. Go to original source... Go to PubMed...
  45. Frías­‑Ibáñez, Á., Palma­‑Sevillano, C., &Farriols­‑Hernando, N. Comorbidity between obsessive­‑compulsive disorder and schizophrenia: Prevalence, explanatory theories, and nosological status. Actasespañolas de Psiquiatría. 2014; 42(1), 28-38.
  46. Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer­‑Lindenberg A, Zink M. Stable cognitive deficits in schizophrenia patients with comorbid obsessive­‑compulsive symptoms: a 12-month longitudinal study. Schizophr Bull 2013;39(6):1261-1271. Go to original source... Go to PubMed...
  47. Pallanti S, Castellini G, Chamberlain SR, Quercioli L, Zaccara G, Fineberg N. A. Cognitive event­‑related potentials differentiate schizophrenia with obsessive­‑compulsive disorder (schizo­‑OCD) from OCD and schizophrenia without OC symptoms. Psychiatry Res. 2009;170:52-60. Go to original source... Go to PubMed...
  48. Cunill R, Castells X, Simeon D. Relationships between obsessive­‑compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta­‑analysis. J Clin Psychiatry 2009;70(1):70-82. Go to original source... Go to PubMed...
  49. Owashi T, Ota A, Otsubo T, Susa Y, Kamijima K. Obsessive­‑compulsive disorder and obsessive­‑compulsive symptoms in Japanese inpatients with chronic schizophrenia - a possible schizophrenic subtype. Psychiatry Res 2010;179(3):241-246. Go to original source... Go to PubMed...
  50. Üçok A, Ceylan ME, Tihan AK, Lapçin S, Ger C, Tükel R. Obsessive compulsive disorder and symptoms may have different effects on schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(2):429-433. Go to original source... Go to PubMed...
  51. Sa AR, Hounie AG, Sampaio AS, Arrais J, Miguel EC, Elkis H. Obsessive­‑compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol. Compr Psychiatry. 2009;50(5):437-442. Go to original source... Go to PubMed...
  52. Ohta M, Kokai M, Morita Y. Features of obsessive­‑compulsive disorder in patients primarily diagnosed withs schizophrenia. Psychiatry Clin Neurosci. 2003; 57:67-74. Go to original source... Go to PubMed...
  53. Singh A, Beniwal RP, Bhatia T, Deshpande, SN. Prevalence and clinical correlations of obsessive­‑compulsive symptoms in schizophrenia. Asian Journal of Psychiatry. 2019; 39, 48-52. Go to original source... Go to PubMed...
  54. Fernandez­‑Egea E, Worbe Y, Bernardo M, Robbins TW. Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia. Psychol Med. 2018;48(16):2668-2675. Go to original source... Go to PubMed...
  55. Reznik I, Yavin I, Stryjer R, Spivak B, Gonen N, Strous R, Mester R, Weizman A, Kotler M. Clozapine in the treatment of obsessive­‑compulsive symptoms in schizophrenia patients: a case series study. Pharmacopsychiatry. 2004;37(2):52-56. Go to original source... Go to PubMed...
  56. Tranulis C, Potvin S, Gourgue M, Leblanc G, Mancini­‑Marie A, Stip E. The paradox of quetiapine in obsessive­‑compulsive disorder. CNS Spectr. 2005;10:356-361. Go to original source... Go to PubMed...
  57. Üçok A, Tükel R, Ozgen G, Saylan M, Uzuner G. Frequency of obsessive compulsive symptoms and disorder in patients with schizophrenia: importance for prognosis. Encephale. 2006;32:41-44. Go to original source... Go to PubMed...
  58. Sevincok L, Akoglu A, Kokcu F. Suicidality in schizophrenic patients with and without obsessive­‑compulsive disorder. Schizophr Res. 2007;90:98-202. Go to original source... Go to PubMed...
  59. Howland RH. Chlorpromazine and obsessive­‑compulsive symptoms. Am J Psychiatry. 1996;153:1503. Go to original source... Go to PubMed...
  60. Diler R. S, Yolga A, Avci A, Scahill L. Risperidone­‑induced obsessive­‑compulsive symptoms in two children. J. Child Adolesc. Psychopharmacol. 2003;13(Suppl 1):89-92. Go to original source... Go to PubMed...
  61. Ke CL, Yen CF, Chen CC, Yang SJ, Chung W, Yang MJ. Obsessive­‑compulsive symptoms associated with clozapine and risperidone treatment: three case reports and review of the literature. Kaohsiung J Med Sci. 2004;20:295-301. Go to original source... Go to PubMed...
  62. Ozer S, Arsava M, Ertugrul A, Demir B. Obsessive compulsive symptoms associated with quetiapine treatment in a schizophrenic patient: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:724-727. Go to original source... Go to PubMed...
  63. Stamouli S, Lykouras L. Quetiapine­‑induced obsessive­‑compulsive symptoms: a series of five cases. J. Clin. Psychopharmacol. 2006;26:396-400. Go to original source... Go to PubMed...
  64. Baker RW, Chengappa KN, Baird JW, Steingard S, Christ MA, Schooler NR. Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry. 1992;53:439-442.
  65. Ertugrul A, Anil Yagcioglu AE, Eni N, Yazici KM. Obsessive­‑compulsive symptoms in clozapine treated schizophrenic patients. Psychiatry Clin Neurosci. 2005;59:219-222. Go to original source... Go to PubMed...
  66. Baker RW, Ames D, Umbricht DS, Chengappa KN, Schooler NR. Obsessive­‑compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo. Psychopharmacol Bull. 1996;32:89-93. Go to PubMed...
  67. Kapur S, Remington G: Serotonin­‑dopamine interaction and its relevance to schizophrenia. Am J Psychiatry. 1996;153:466-476. Go to original source... Go to PubMed...
  68. Kwon JS, Joo YH, Nam HJ, Lim M, Cho EY, Jung MH, Choi JS, Kim B, Kang DH, OhS, Park T, Hong KS. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics­‑induced obsessive­‑compulsive symptoms. Arch Gen Psychiatry. 2009;66(11):1233-41. Go to original source... Go to PubMed...
  69. Glick ID, Poyurovsky M, Ivanova O, Koran ML. Aripiprazole in schizophrenia patients with comorbid obsessive­‑compulsive symptoms: an open­‑label study of 15 patients. J Clin Psychiatry. 2008;69:1856-1859. Go to original source... Go to PubMed...
  70. Juven­‑Wetzler A, Fostick L, Cwikel­‑Hamzany S, Balaban E, Zohar J. Treatment with Ziprasidone for schizophrenia patients with OCD. European Neuropsychopharmacology. 2014;24(9):1454-1462. Go to original source... Go to PubMed...
  71. Berman I, Sapers BL, Chang HH, Losonczy MF, Schmildler J, Green AI. Treatment of obsessive­‑compulsive symptoms in schizophrenic patients with clomipramine. J. Clin. Psychopharmacol. 1995;15:206-210 Go to original source... Go to PubMed...
  72. Poyurovsky M, Weizman A. Intravenous clomipramine for a schizophrenic patients with obsessive compulsive symptoms. Am J Psychiatry. 1998;155:193. Go to original source... Go to PubMed...
  73. Rahman MS, Grace JJ, Pato MT, Priest B. Sertraline in the treatment of clozapine­‑induced obsessive­‑compulsive disorder. Am J Psychiatry. 1998;155:1629-1630. Go to original source...
  74. Reznik I, Sirota P. Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics. J Clin Psychopharmacol. 2000;20(4):410-416. Go to original source... Go to PubMed...
  75. Dwivedi S, Pavuluri M, Heidenreich J, Wright T. Response to fluvoxamine augmentation for obsessive and compulsive symptoms in schizophrenia. J Clin Adolesc Psychopharmacol. 2002;12:69-70. Go to original source... Go to PubMed...
  76. Poyurovsky M, Glick I, Koran LM. Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive­‑compulsive symptoms. J Psychopharmacol. 2010;24:861-866. Go to original source... Go to PubMed...
  77. Stryjer R, Dambinsky Y, Timinsky I, Green T, Kotler M, Weizman A, Spivak B. Escitalopram in the treatment of patients with schizophrenia and obsessive­‑compulsive disorder. International Clinical Psychopharmacology. 2013; 8(2),96-98. Go to original source... Go to PubMed...
  78. Rubin­‑Kahana DS, Shelef A, Weizman A, Gothelf D, Tyminski I, Spivak B, Stryjer R. The effectiveness of high­‑dose escitalopram in the treatment of patients suffering from schizophrenia with comorbid obsessive­‑compulsive disorder: an open­‑label study. Int Clin Psychopharmacol. 2019;34(4):179-183. Go to original source... Go to PubMed...
  79. https://postupy­‑pece.psychiatrie.cz
  80. Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthøj B, Gattaz WF, Florence T, Möller HJ, WFSBP Task Force on Treatment Guidelines for Schizophrenia. (2015). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia part 3: update 2015 management of special circumstances: depression, Suicidality, substance use disorders and pregnancy and lactation. The World Journal of Biological Psychiatry. 2015;16(3):142-170. DOI: 10.3109/15622975.2015.1009163 Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.